[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339381-105":59,"doc-detail-339381-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","plasma-derived-extracellular-matrix-for-xenofree-and-cost-effective-organoid-modeling-for-hepatocellular-carcinoma","Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma","","Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality, while current organoid modeling is constrained by high cost, operational complexity, and contamination risks linked to animal-derived extracellular matrix (ECM). Synthetic ECM options often fail to reproduce the native tissue’s biocomplexity. This study develops a physiologically relevant HCC organoid system using plasma-derived ECM as a scaffold and nutritive biomatrix with adjustable cellularity to better emulate heterogenous HCC microenvironments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plasma-derived-extracellular-matrix-for-xenofree-and-cost-effective-organoid-modeling-for-hepatocellular-carcinoma/339381/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plasma-derived-extracellular-matrix-for-xenofree-and-cost-effective-organoid-modeling-for-hepatocellular-carcinoma/339381.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are organoid models difficult to use for HCC research today?","Question",{"text":112,"@type":113},"Costs, experimental complexity, and contamination risks from animal-derived ECM limit broader application. Synthetic ECM substitutes also struggle to replicate native biocomplexity fully.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the HCC organoids generated in this study?",{"text":117,"@type":113},"HUH-7 hepatoma cells were cultured either alone for a homogenous model or together with mesenchymal stromal cells and endothelial cells for a heterogeneous model in plasma-rich platelet-derived ECM. Organoids were grown for 14 days and assessed for cancer-related properties.",{"name":119,"@type":110,"acceptedAnswer":120},"What advantages did the heterogeneous organoids show?",{"text":121,"@type":113},"Heterogeneous organoids demonstrated enhanced invasion potential, increased cancer stem cell populations, and late-stage HCC genetic signatures compared with homogenous organoids, while maintaining viability and chemoresistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339381,1790469150,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","El-Derby et al. Journal of Translational Medicine (2024) 22:487  \n[https://doi.org/10.1186/s12967-024-05230-7](https://doi.org/10.1186/s12967-024-05230-7)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nPlasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma  \nAzza M. El-Derby 1, Mennatallah A. Khedr 1, Nehal I. Ghoneim 1, Mahmoud M. Gabr2, Sherry M. Khater2 and Nagwa El-Badri 1*  \nAbstract  \nBackground Hepatocellular carcinoma (HCC) causes significant cancer mortality worldwide. Cancer organoidscan serve as useful disease models by high costs, complexity, and contamination risks from animal-derived products and extracellular matrix (ECM) that limit its applications. On the other hand, synthetic ECM alternatives also have limitations in mimicking native biocomplexity. This study explores the development of a physiologically relevant HCC organoid model using plasma-derived extracellular matrix as a scaffold and nutritive biomatrix with different cellularity components to better mimic the heterogenous HCC microenvironment. Plasma-rich platelet is recognized for its elevated levels of growth factors, which can promote cell proliferation. By employing it as abiomatrix for organoid culture there is a potential to enhance the quality and functionality of organoid models for diverse applications in biomedical research and regenerative medicine and to better replicate the heterogeneous microenvironment of HCC.  \nMethod To generate the liver cancer organoids, HUH-7 hepatoma cells were cultured alone (homogenous model) or with human bone marrow-derived mesenchymal stromal cells and human umbilical vein endothelial cells (heterogeneous model) in plasma-rich platelet extracellular matrix (ECM) . The organoids were grown for 14 days and analyzed for cancer properties including cell viability, invasion, stemness, and drug resistance.  \nResults HCC organoids were developed comprising HUH-7 hepatoma cells with or without human mesenchymal stromal and endothelial cells in plasma ECM scaffolds. Both homogeneous (HUH-7 only) and heterogeneous (mixed cellularity) organoids displayed viability, cancer hallmarks, and chemoresistance. The heterogeneous organoids showed enhanced invasion potential, cancer stem cell populations, and late-stage HCC genetic signatures versus homogeneous counterparts.  \nConclusion The engineered HCC organoids system offers a clinically relevant and cost-effective model to study liver cancer pathogenesis, stromal interactions, and drug resistance. The plasma ECM-based culture technique could enable standardized and reproducible HCC modeling. It could also provide a promising option for organoid culture and scaling up.  \n*Correspondence:  \nNagwa El-Badri [nel badri@zewailcity.edu.eg](nel badri@zewailcity.edu.eg)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made","cbCaisM2BZ4ZtsRR","https://ap.wps.com/l/cbCaisM2BZ4ZtsRR","pdf",2574202,16,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusion\n# Keywords\n## Background","[{\"question\":\"Why are organoid models difficult to use for HCC research today?\",\"answer\":\"Costs, experimental complexity, and contamination risks from animal-derived ECM limit broader application. Synthetic ECM substitutes also struggle to replicate native biocomplexity fully.\"},{\"question\":\"How were the HCC organoids generated in this study?\",\"answer\":\"HUH-7 hepatoma cells were cultured either alone for a homogenous model or together with mesenchymal stromal cells and endothelial cells for a heterogeneous model in plasma-rich platelet-derived ECM. Organoids were grown for 14 days and assessed for cancer-related properties.\"},{\"question\":\"What advantages did the heterogeneous organoids show?\",\"answer\":\"Heterogeneous organoids demonstrated enhanced invasion potential, increased cancer stem cell populations, and late-stage HCC genetic signatures compared with homogenous organoids, while maintaining viability and chemoresistance.\"}]","Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma | PDF",1790029903,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea0cb2649361fdb0211d71704a297552.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1e29c89907c79c1fa8cc9e8063b9e13.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d08788aeccd6171bebd0a5f01f9812c.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41bff104898b69842f9818810153c3aa.webp",980,1306]